top of page

Our Blog

Search


Clinical Outsourcing Models – Approaches to Outsourcing Strategy
When a drug or medical device candidate is ready for clinical investigation, organisations have the choice to utilise three common...

David Jones
4 min read


Clinical Trial Randomization: Handle with Care – One Chance, No Regrets, Interview with IDDI
Randomization in clinical trials ensures unbiased assignment of participants to treatment groups. It minimizes confounding variables and...

David Jones
5 min read


Supporting World Sickle Cell Day 2023
Sickle Cell Disease (SDC) is an inherited blood disorder which is estimated to affect between 1-3 million Americans. It...

David Jones
2 min read


How do European Regulatory Policies Support Biotech Investment?, Interview with Sam Vakili
In continuation of our series of interviews, Sam Vakili, Founder & CEO, INVEST.IN.TEK shared with me his views on the impact of European...

David Jones
3 min read


Current Trends in Biotech Investments in Europe, Interview with Sam Vakili
In continuation of our series of interviews, Sam Vakili, Founder & CEO, INVEST.IN.TEK shared with me his opinion on the current trends...

David Jones
3 min read


Improving LGBT+ Representation in Clinical Research
Taking the US as an example, now 7.1% of the population identify as LGBT+, this has doubled since 2012 when it was reported as low as...

David Jones
2 min read


Top 3 Ways to Increase Clinical Trial Participation from Under-Represented Patient Groups
Patient groups typically under-represented in clinical research include, but not limited to, Racial & Ethnic minorities, Older adults,...

David Jones
2 min read


The Role Non-Profit & Academic Institutions Play in Clinical Research
Non-profits such as Research, Patient Advocacy Groups, Charitable Bodies and Academic Institutions play a vital role in global clinical...

David Jones
2 min read


The Evolving Trial Supply Landscape in a Post-Pandemic World
During the global pandemic, an unsurprising 84% of biopharmaceutical companies reported that they implemented new approaches during COVID-19

Alex O’Leary
2 min read
bottom of page